Remembering Donald Baim

Among the most extraordinary developments both in clinical medicine and in the medical device industry over the past 30 years has been the birth and growth of interventional cardiology. IN VIVO remembers Donald Baim, one of the pioneers of the field, who died on November 6, 2009 at the age of 60.

Among the most extraordinary developments both in clinical medicine and in the medical device industry over the past 30 years has been the birth and growth of interventional cardiology (IC). The specialty has become so well accepted that it is easy to forget how young it is—young enough that many of the pioneering clinicians who built this area are still involved in its continuing growth. One of those pioneers was Donald S. Baim, MD, who died on November 6, 2009, at the age of 60.

At the time of his death, Baim was chief medical and scientific officer of Boston Scientific Corp., a position...

More from Archive

More from In Vivo

Deals In Depth: June 2025

 
• By 

Five $1bn+ alliances were penned in June, and four exceeded $2bn.

Global Pharma Interest In Korea Undeterred Despite Political Roller Coaster

 
• By 

Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.

Podcast: Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

 
• By 

Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.